Neutralization of human respiratory syncytial virus (HRSV) by monoclonal antibodies specific for the G protein was evaluated in a microneutralization test. Only certain antibodies showed some degree of neutralization, reflected in a reduction of virus titre (10-20 times maximum), compared with negative controls. In contrast, a pool of antibodies that recognized conserved, group-specific and strainspecific epitopes showed a significant increase in virus neutralization (up to 500-1000 times). By testing binary, tertiary and quaternary combinations, four antibodies were identified which showed maximal effect in the neutralization test. These findings are discussed in terms of the location of antibody binding sites in the G protein primary structure and their relevance for HRSV neutralization and immunobiology.
Neutralization of human respiratory syncytial virus (HRSV) by monoclonal antibodies specific for the G protein was evaluated in a microneutralization test. Only certain antibodies showed some degree of neutralization, reflected in a reduction of virus titre (10-20 times maximum), compared with negative controls. In contrast, a pool of antibodies that recognized conserved, group-specific and strainspecific epitopes showed a significant increase in virus neutralization (up to 500-1000 times). By testing binary, tertiary and quaternary combinations, four antibodies were identified which showed maximal effect in the neutralization test. These findings are discussed in terms of the location of antibody binding sites in the G protein primary structure and their relevance for HRSV neutralization and immunobiology.
Human respiratory syncytial virus (HRSV) is classified in the genus Pneumovirus, family Paramyxoviridae. This virus is the leading cause of severe respiratory infections in very young children (review by Collins et al., 1996) . HRSV isolates have been classified into two antigenic groups (Anderson et al., 1985 ; Mufson et al., 1985) . Both genetic and antigenic heterogeneity have been observed among isolates of the same group Cane & Pringle, 1995) .
HRSV has two surface glycoproteins (G and F) which are targets of the neutralizing antibodies present in human convalescent sera. High levels of circulating antibodies correlate with protection against HRSV infections or reduction of disease severity (Crowe, 1996) . In addition, small laboratory animals immunized with either purified antigens (F or G) (Walsh et al., 1987) or vaccinia virus recombinants expressing F or G proteins (Olmsted et al., 1986 ; Stott et al., 1987) are protected against challenge with live HRSV. Thus, antigenic characterization of the F and G molecules and studies of Author for correspondence : Jose! A. Melero.
Fax j34 91 5097919. e-mail jmelero!isciii.es antibody mediated virus neutralization are important for development of effective immunoprophylactic or therapeutic measures.
The G protein binds to an as yet unidentified receptor on the surface of susceptible cells (Levine et al., 1987) . It is a type II glycoprotein, synthesized as a 32 kDa precursor, which is heavily glycosylated with both O-and N-linked carbohydrates (Wertz et al., 1989 ; Collins & Mottet, 1992) . The proposed receptor-binding site is located in a central conserved segment of the G protein ectodomain where four cysteines are closely spaced. Flanking this region there are two hypervariable segments with sequence similarity to the mucins secreted by epithelial cells.
The G molecule has three types of epitopes : (i) conserved, shared by all human isolates, (ii) group-specific, shared by viruses of the same antigenic group and (iii) strain-specific or variable, present only in a subset of viruses of the same antigenic group . Epitopes of the first two types are located in the central conserved segment of the G molecule whereas the strain-specific epitopes are restricted almost exclusively to the variable C-terminal one-third (review by Melero et al., 1997) .
Polyclonal antibodies induced in mice by either recombinant vaccinia virus or purified G protein neutralize HRSV efficiently (Levine et al., 1987 ; Walsh et al., 1989) . In contrast, monoclonal antibodies specific for the G protein obtained so far have only marginal effects on virus neutralization (Anderson et al., 1988 ; Garcı! a-Barreno et al., 1989 ; Walsh et al., 1989 ; Martı! nez et al., 1997) . Since a polyclonal rather than a monoclonal immune response is elicited after natural infection, we decided to explore the capacity of mixtures of anti-G monoclonal antibodies to neutralize virus infectivity.
The microneutralization assay described by Anderson et al. (1988) was adapted to test the reduction of infectious units (Long strain) after pre-incubation with anti-G antibodies. Three different amounts of virus were incubated with serial threefold dilutions of hybridoma supernatants before being used to infect Hep-2 cell monolayers. The extent of virus infection was evaluated 72 h later by fixing the cells and determining the amount of viral antigen by ELISA, using a rabbit antiserum Virus-antibody mixtures were used to infect Hep-2 monolayers growing in microtitre plates. Seventy-two hours later, the cells were fixed and the extent of virus replication in each well was evaluated by ELISA, as described by Anderson et al. (1988) . Background values for uninfected cells were subtracted. Symbols are indicated in panel (A). Negative control was culture medium without antibody. Total pool was a mixture of antibodies 021/1G, 021/21G, 021/19G, 021/2G, 63G, 68G, 25G, 78G, 64G and 59G.
specific for the F glycoprotein followed by peroxidase-labelled anti-rabbit Ig. Fig. 1 shows the results obtained with representative antibodies. Certain antibodies, such as 021\2G, had no effect on the absorbance values even at the lowest antibody dilution. Others, such as 64G, reduced to some extent the maximum specific absorbance ; this effect was more evident with the lowest amount of virus ( Fig. 1 C) .
When a mixture of antibodies 021\2G and 64G was tested in the microneutralization assay an enhanced reduction of the maximum absorbance was observed. This enhanced neutralization was even more evident with a pool of antibodies that recognized conserved, group-specific and strain-specific epitopes of the G glycoprotein. Noteworthy, the decline of maximum absorbance with the mixture of 021\2G and 64G had two slopes (seen only with virus dilutions 1 : 100 and 1 : 200), indicating that a fraction of the virus remained resistant to neutralization even at the lowest antibody dilutions. A smaller fraction of virus remained resistant to neutralization with the pool of antibodies. Anderson et al. (1988) and Walsh et al. (1989) have reported similar results with different sets of anti-G monoclonal antibodies. When the fraction of nonneutralized virus was grown up and tested again in the microneutralization assay, it behaved as wild-type (Anderson et al., 1988) . Thus, partial neutralization is not the result of escape mutants resistant to antibodies present in the virus stock.
Since HRSV is a labile virus whose titre is changed by manipulations, such as freeze-thawing, we decided to explore the effect of antibodies in the reciprocal assay i.e. mixing fixed amounts of antibodies with serial dilutions of virus. In this case, the neutralizing effect of antibodies would be reflected in displacements of the titration curve towards lower virus dilutions (independent of the virus titre used in each assay). Representative results are shown in Fig. 2 . Again, certain antibodies had only marginal effects on virus titre (e.g. antibody 021\1G, panel A). Noteworthy, antibody 021\2G -which had no effect in reduction of maximum absorbance when tested as in Fig. 1 -reduced virus titre substantially (about 5 times) (Fig. 2 A) . Among individual antibodies, maximal reduction of virus titre was observed with antibody 64G (about 25 times) and intermediate effects were seen with antibodies 78G or 63G. A much larger reduction of virus titre (about 800 times) was observed again with the pool of antibodies (Fig. 2 A) .
Pairs of antibodies were also tested for virus titre reduction. In some cases (e.g. antibodies 021\2G and 78G ; Fig. 2 B) , individual antibodies showed some degree of virus neutralization but no enhancement was observed with the antibody pair. In other cases, however, the extent of neutralization was increased with the antibody pair (e.g. antibodies 021\2G and 64G ; Fig. 2 C) . Certain antibodies, such as 021\1G (Fig. 2 D) , which had no effect on virus titre reduction showed, nevertheless, significant synergy when mixed with other antibodies, such as 021\2G.
The reductions of virus titre attained with all antibody pairs are shown in Fig. 3 (B) . In most cases, virus neutralization was higher with the pair of antibodies than with each antibody tested individually. Certain antibodies, such as 021\21G, showed only marginal enhancement of virus titre reduction in all antibody pairs, except with 021\2G. Maximum synergy RSV neutralization by anti-G antibodies RSV neutralization by anti-G antibodies was observed with antibodies 64G or 59G mixed with antibody 021\2G. Significant enhancement of neutralization was also observed with antibodies 64G or 59G mixed with 021\1G, 63G or 68G. The antibodies depicted in Fig. 3 had similar titres in an ELISA test using an extract of Hep-2 cells infected with Long virus as the antigen source (not shown). Moreover, the ELISA titre of antibody mixtures was intermediate to those of individual antibodies (not shown). Thus, neither difference on virus titre reduction between individual antibodies or enhanced neutralization by antibody mixtures could be correlated with antigen binding.
In order to identify the minimal combination of antibodies that neutralized as the total pool, tertiary combinations of antibodies 021\2G and 64G with all others depicted in Fig. 3 were tested. Antibodies 021\1G, 021\21G and 63G showed enhancement of virus titre reduction (not shown). Considering this result, the quaternary combination 021\1G, 021\2G, 63G and 64G was also tested. As shown in Fig. 2 (E) (pool C), the mixture of these four antibodies reduced the virus titre to a similar extent as the total pool of antibodies. Moreover, the quaternary combination had more effect in virus titre reduction than pool A, which included antibodies binding to conserved and group-specific epitopes, or pool B, which included antibodies that recognized strain-specific epitopes. Thus, maximal effect on virus titre reduction requires the contribution of antibodies that recognized the three types of epitopes identified in the G molecule. It is worth mentioning that the level of virus titre reduction observed with the total pool of antibodies is comparable to that afforded by polyclonal sera CCBH I. Martı! nez and J. A. Melero. I. Martı! nez and J. A. Melero. Fig. 3 . Location of epitopes in the G protein primary structure and reduction of virus titre by antibody pairs. (A) Diagram of the G protein amino acid sequence denoting the transmembrane region (thick line), the mucin-like regions and the cysteine residues ($). Open arrows indicate the location of amino acid changes in escape mutants that ablated conserved (021/1G) or group-specific epitopes (021/2G and 021/19G). Filled arrows indicate the location of amino acid changes that eliminated strain-specific epitopes (68G, 25G, 78G, 59G and 64G). The reactivity of synthetic peptides with the strain-specific antibody 63G identified amino acids 204-209 (shaded rectangle) as essential for the integrity of this epitope (review by Melero et al., 1997) . The conserved epitope recognized by antibody 021/21G, used in this study, has not yet been mapped. (B) Numbers indicate the reduction of virus titre (RVT) observed with individual antibodies (diagonal) and with pairs of antibodies when tested as in Fig. 2 . Virus titre was calculated as the reciprocal of virus dilution that gave 50 % of the maximum absorbance. RVT l titre of virus in the presence of control medium/titre of virus in the presence of antibody. Open rectangles indicate the antibody pairs with RVT values above 20 times and shaded rectangles those with values above 50 times. from mice inoculated with recombinant vaccinia virus that expressed the G protein (not shown).
The specificity of virus neutralization was further evaluated by testing the reduction of virus titre with mutant Rc793\10. This mutant was selected from the Long strain by resistance to an antibody (c793) that recognized a conserved epitope of the G glycoprotein (Rueda et al., 1994) . Rc793\10 has multiple A-G transitions in the G protein gene that ablate all the conserved and group-specific epitopes. As expected, the mixture of antibodies that recognized conserved and groupspecific epitopes of the G protein (pool A) had no effect on the titre of Rc793\10 (Fig. 2 F) . Pool B, which recognized strainspecific epitopes of the G protein, still had a significant effect on virus titre reduction and it was similar to the effect of the total pool of anti-G antibodies. Thus, genetic mutations that ablate antibody binding also abolish virus neutralization afforded by the same antibodies.
Other studies have described enhanced neutralization of HRSV by mixtures of monoclonal antibodies. Anderson et al. (1988) showed that the neutralization index of certain monoclonal antibodies specific for the fusion (F) protein was increased when mixed with other anti-F or anti-G antibodies. Walsh et al. (1989) have also published limited data on enhanced neutralization with certain pairs of anti-G monoclonal antibodies. However, our study is the first systematic analysis of enhanced neutralization by anti-G antibodies whose epitopes were mapped previously in the G protein sequence (Fig. 3 A) .
The results presented here raise important questions about the mechanism of HRSV neutralization. Since the highest synergy was observed with antibodies that did not compete for antigen binding (Garcı! a-Barreno et al., 1989) , it is possible that enhanced neutralization is the result of binding several antibody molecules to the same G protein. In agreement with this hypothesis antibodies 64G and 59G, which showed maximal effects when tested individually but competed for simultaneous binding to the antigen, did not act synergistically as a pair (Fig. 3 B) . Likewise, complete neutralization of Newcastle disease virus requires binding of antibodies to four separate sites of the haemagglutinin-neuraminidase (Iorio & Bratt, 1984) .
We have suggested that the C-terminal one-third of the G polypeptide folds back in the three-dimensional structure, so that the C-terminal end is in close proximity to the cysteine cluster . If this is the case, the epitopes of antibodies 021\1G, 021\2G, 63G and 64G, which afforded maximal neutralization, would be in close proximity to the putative receptor binding site (Johnson et al., 1987) of the native G molecule. Binding of those four antibodies may provide maximal steric hindrance for interaction of G with its cellular receptor. Antibodies 64G and 59G are IgMs and it is possible that antibody isotype may also influence steric inhibition of receptor binding.
Synergistic effects on virus neutralization by mixtures of monoclonal antibodies have been reported for vesicular stomatitis virus (Volk et al., 1982) , Newcastle disease virus (Iorio & Bratt, 1984) and La Crosse virus (Kingsford, 1984) . A synergistic effect on neutralization was also observed with mixtures of hyperimmune immunoglobulin and monoclonal antibodies specific for human immunodeficiency virus (Mascola et al., 1997) . It has been suggested that, in those studies, heterogeneity of viral glycoproteins could explain both partial neutralization by monoclonal antibodies and enhanced neutralization by antibody pools. However, phenotypic rather than genetic heterogeneity should be the determinant in all those cases since viruses recovered after partial neutralization behaved as wild-type.
The G protein of HRSV is heavily glycosylated and it is conceivable that different molecules may have different carbohydrate side-chains. It has been shown that carbohydrates influence the antigenicity of the G glycoprotein (Garcı! a-Beato et al., 1996) . However, since carbohydrates do not influence conserved and group-specific epitopes , it is difficult to envisage that carbohydrate heterogeneity could be responsible for either partial neutralization by individual antibodies or enhanced neutralization by antibody mixtures.
Hyperimmune globulin preparations from human plasma pools with high neutralizing titres are now available for prophylactic treatment of HRSV infections (Hemming et al., 1995) . It is desirable that, in the future, pools of wellcharacterized monoclonal antibodies should replace the immunoglobulin preparations. The results presented here are a preliminary step in that direction.
